The TB laboratory of the future: macrophage-based selection of XDR-TB therapeutics

Author： Martins Marta   Viveiros Miguel   Amaral Leonard  

Publisher： Future Medicine

ISSN： 1746-0913

Source： Future Microbiology, Vol.3, Iss.2, 2008-04, pp. : 135-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

XDR-TB genome sequencing: a glimpse of the microbiology of the future

By Loman NJ   Pallen MJ  

Future Microbiology, Vol. 3, Iss. 2, 2008-04 ,pp. : 111-113

Future Medicine

Access to resources Recommend Favorite

Back to the future: host-targeted chemotherapeutics for drug-resistant TB

By Napier Ruth J   Shinnick Thomas M   Kalman Daniel  

Future Microbiology, Vol. 7, Iss. 4, 2012-04 ,pp. : 431-435

Future Medicine

Access to resources Recommend Favorite

Understanding TB persistence

By Nickerson C.A.  

Trends in Microbiology, Vol. 8, Iss. 8, 2000-08 ,pp. : 352-353

Elsevier

Access to resources Recommend Favorite

Importance of improved TB diagnostics in addressing the extensively drug-resistant TB crisis

By Parrish Nicole   Carrol Karen  

Future Microbiology, Vol. 3, Iss. 4, 2008-08 ,pp. : 405-413

Future Medicine

Access to resources Recommend Favorite

A new resource for TB diagnostics developers

By Qin Zhi Zhen   Pai Madhukar  

Future Microbiology, Vol. 8, Iss. 12, 2013-12 ,pp. : 1507-1509

Future Medicine

Access to resources Recommend Favorite